Turkish of the SARS-CoV-2 Anxiety Scale

Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale

The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determining the anxiety levels of individuals in the society and supporting them psychologically is of great importance. In order to achieve this, healthcare professionals working clinically or academically have important duties. This study was planned to test its validity and reliability in order to adapt the Coronavirus Anxiety Scale to Turkish.

Study Overview

• Status: Unknown
• Conditions: Anxiety; SARS-CoV Infection
• Intervention / Treatment: Other: survey work

Detailed Description

Coronaviruses can be seen in animals and humans as infections that can be mild and severe in society. The SARS-CoV-2 virus, a type of coronavirus, started in China in December 2019 and has spread worldwide as of January 2020. The absence of vaccine and treatment for SARS-CoV-2 disease threatens health worldwide and significantly affects people's daily routine. In China, where the pandemic started, shopping malls and schools were closed for a while, and city entrances and exits were stopped for a while. Although there are similar practices in excellence, as in many countries, measures such as curfew, nursery and school closure continue to be taken for under-20s and over-65s. . The coronavirus epidemic that affects our entire life is not fully known about the disease process, WHO is defined as the pandemic of the epidemic, the nearest contact is the greatest risk of transmission, and the loss of many lives during this process affects all individuals in the society negatively and increases the level of anxiety .

It is a psychological reaction involving many emotions such as anxiety, stress, or anxiety, fear and distress that arise in a situation that threatens the safety of the individual. Conditions such as uncertainty, various diseases (cancer, epidemic, etc.) and losing a relative can cause anxiety. Outbreaks that occur suddenly and are at risk of death are among these reasons.

• Study Type: Interventional
• Enrollment (Anticipated): 300
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Eskisehir, Turkey
    • Recruiting
    • Eskisehir Osmangazi University
    • Contact: AYFER AÇIKGÖZ; Phone Number: 05352919374

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 60 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

inclusion criteria;

• individuals agree to participate in the study
• 18 years old,
• Lack of visual obstacle,
• Knowing how to speak, read and write in Turkish.

Exclusion criteria;

• individuals refuse to participate in the study
• 18 years old,
• Visually impaired,
• Does not know how to speak, read and write in Turkish

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: volunteer group; Only volunteer participants will be included in the research. Survey forms will be sent to individuals online. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.	Other: survey work; Survey forms will be sent to individuals online. Information about the study will be given to individuals with the informative text at the beginning of the questionnaire form. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Anxiety in SARS-CoV-2	anxiety increase in SARS-CoV-2 in humans.	4 weeks
Ratio of SARS-CoV-2 anxiety scale to beck anxiety scale	The ratio of SARS-CoV-2 anxiety scale to beck anxiety scale is similar.	4 weeks

Collaborators and Investigators

• Sponsor: DILEK SAYIK
• Investigators: Principal Investigator: DILEK SAYIK, Eskisehir Osmangazi Universty

Publications and helpful links

General Publications

• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
• Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. J Sport Health Sci. 2020 Mar;9(2):103-104. doi: 10.1016/j.jshs.2020.02.001. Epub 2020 Feb 4. No abstract available.
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7. Erratum In: J Med Virol. 2020 Oct;92(10):2249.
• Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393-401. doi: 10.1080/07481187.2020.1748481. Epub 2020 Apr 16.
• Benli, S. S., & Yıldırım, A. (2017). Hemşirelerde yaşam doyumu ve ölüme karşı tutum arasındaki ilişki. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 6(4), 167-179
• Faraji A, Karimi M, Azizi SM, Janatolmakan M, Khatony A. Occupational stress and its related demographic factors among Iranian CCU nurses: a cross-sectional study. BMC Res Notes. 2019 Sep 27;12(1):634. doi: 10.1186/s13104-019-4674-5.

Study record dates

Study Major Dates

• Study Start (Actual): July 24, 2020
• Primary Completion (Anticipated): March 24, 2021
• Study Completion (Anticipated): April 24, 2021

Study Registration Dates

• First Submitted: July 25, 2020
• First Submitted That Met QC Criteria: July 28, 2020
• First Posted (Actual): July 29, 2020

Study Record Updates

• Last Update Posted (Actual): December 23, 2020
• Last Update Submitted That Met QC Criteria: December 22, 2020
• Last Verified: December 1, 2020

More Information

Terms related to this study

• Keywords: Anxiety; COVID-19; Coronavirus Anxiety Scale
• Additional Relevant MeSH Terms: Mental Disorders; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Severe Acute Respiratory Syndrome; Anxiety Disorders
• Other Study ID Numbers: DSAYIK2; Ayfer AÇIKGÖZ (Other Identifier: ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ); ERTUĞRUL ÇOLAK (Other Identifier: ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ); DENİZ YİĞİT (Other Identifier: ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ); ÖZLEM MUMCU (Other Identifier: ESKİŞEHİR ŞEHİR HASTANESİ)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: It is planned to be published in the journal after the study is completed. The study will be shared with other researchers after it is published in the journal.
• IPD Sharing Time Frame: will be shared after the work is finished.
• IPD Sharing Access Criteria: It will be shared with researchers who want to use the anxiety scale.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No